Gupta S, Rajvanshi P, Irani A N, Palestro C J, Bhargava K K
Marion Bessin Liver Research Center and Gastroenterology Division, Department of Medicine, Jack and Pearl Resnick Campus, Bronx, New York, USA.
J Pathol. 2000 Feb;190(2):203-10. doi: 10.1002/(SICI)1096-9896(200002)190:2<203::AID-PATH521>3.0.CO;2-2.
To determine whether liver repopulation with cell transplantation could be of therapeutic value in acute hepatic failure, it is necessary to establish the fate of transplanted hepatocytes. This study used dipeptidyl peptidase IV-deficient F344 rats as recipients to analyse the engraftment and proliferation of transplanted hepatocytes. Syngeneic hepatocytes were transplanted intrasplenically 24-30 h after induction of liver injury by D-galactosamine (GalN). Portosystemic shunting was analysed with 99m-Tc-labelled albumin microspheres. GalN-treated rats showed characteristic hepatic necrosis, inflammation, gamma-glutamyl transpeptidase activation, and regenerative activity, without increased portosystemic shunting (>99% 99m-Tc activity was in the liver in normal and GalN-treated rats). Transplanted cells entered hepatic sinusoids promptly and were observed in liver plates at 48 h. The number of transplanted cells increased in GalN-treated rats by approximately seven-fold (range two- to 12-fold), along with evidence for DNA synthesis between 3 and 14 days after cell transplantation and greater prevalence of larger transplanted cell clusters. These findings indicate that the liver can be safely repopulated in animals with acute liver failure, although the time required for regenesis of plasma membrane structures and proliferation in transplanted hepatocytes will need to be considered in developing therapeutic strategies.
为了确定细胞移植实现肝脏细胞重新填充在急性肝衰竭中是否具有治疗价值,有必要明确移植肝细胞的命运。本研究使用二肽基肽酶IV缺陷的F344大鼠作为受体,分析移植肝细胞的植入和增殖情况。在通过D-半乳糖胺(GalN)诱导肝损伤后24 - 30小时,将同基因肝细胞脾内移植。用99m锝标记的白蛋白微球分析门体分流情况。经GalN处理的大鼠表现出典型的肝坏死、炎症、γ-谷氨酰转肽酶激活和再生活性,且门体分流未增加(正常大鼠和经GalN处理的大鼠中>99%的99m锝活性存在于肝脏)。移植细胞迅速进入肝血窦,并在48小时时在肝板中被观察到。在经GalN处理的大鼠中,移植细胞数量增加了约7倍(范围为2至12倍),同时有证据表明在细胞移植后3至14天存在DNA合成,且较大移植细胞簇的发生率更高。这些发现表明,在急性肝衰竭动物中肝脏能够安全地实现细胞重新填充,不过在制定治疗策略时需要考虑移植肝细胞中质膜结构再生和增殖所需的时间。